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ABSTRACT: Wound repair in adult mammals typically ends with the formation
of a scar, which prevents full restoration of the function of the healthy tissue,
although most of the wounded skin heals. Rapid and functional recovery of major
wound injuries requires therapeutic approaches that can enhance the healing
process via overcoming mechanical and biochemical problems. In this study, we
showed that self-assembled heparin-mimetic peptide nanofiber gel was an effective
bioactive wound dressing for the rapid and functional repair of full-thickness
excisional wounds in the rat model. The bioactive gel-treated wounds exhibited
increased angiogenesis (p < 0.05), re-epithelization (p < 0.05), skin appendage
formation, and granulation tissue organization (p < 0.05) compared to sucrose-
treated samples. Increased blood vessel numbers in the gel-treated wounds on day 7 suggest that angiogenesis played a key role in
improvement of tissue healing in bioactive gel-treated wounds. Overall, the angiogenic heparin-mimetic peptide nanofiber gel is a
promising platform for enhancing the scar-free recovery of acute wounds.
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■ INTRODUCTION
Cutaneous wound healing is a morphogenic response against
anything compromising tissue integrity and serves to restore
the anatomic continuity and homeostasis of the affected tissue.1
As a dynamic and complex process, wound healing occurs
through a series of finely orchestrated interactions between
cells, extracellular elements, and signaling molecules that are
present in the damaged tissue area.2 The tissue regeneration
process begins immediately following any type of trauma, and is
characterized by four partially overlapping steps: (i) hemostasis,
(ii) inflammation, (iii) proliferation (angiogenesis, granulation,
re-epithelialization), and (iv) tissue remodeling.3−5 Following
the formation of a blood clot, macrophages and granulocytes
infiltrate the wound area and facilitate the production of
granulation tissue, which contains an extensive network of
capillaries and supports the subsequent migration, proliferation,
and differentiation of fibroblasts within the wound area. This
process enables rapid but partial restoration of tissue
functionality, and is typically completed within a few weeks.
Preliminary closure of wounds is followed by a prolonged
remodeling phase, which lasts 6−12 months6 and involves the
transformation of granulation tissue into a mature scar through
regression of the capillary network.7−9 Nevertheless, even
mature scars can only reach about 70% of the tensile strength of
normal skin.6 In addition, the amount of hair follicles and sweat
and sebaceous glands, which are also called skin appendages,
are also reduced in scar tissue compared to unwounded
skin.10,11
Following an injury, damaged capillary blood vessels are
rapidly reconstructed to provide nutrients, oxygen and other
blood constituents to the injured skin. This process may occur
either through angiogenesis, which involves the extension of the
existing blood vessel network through the proliferation of
endothelial cells5 or by vasculogenesis, which is the de novo
formation of blood vessels through the migration of endothelial
progenitor cells to the wound bed.12,13 Wound healing is
compromised if any of these processes fails to occur,14 and
factors such as hypoxia and secretion of growth factors are
responsible for triggering angiogenic or vasculogenic activity at
the wound site. Fibroblast growth factor-2 (FGF-2) and
vascular endothelial growth factor (VEGF) in particular are
vital for the repair of wound injuries.15 It has been shown that
decreased angiogenesis causes cell death as an indicator if
impaired wound healing.16 Heparan sulfate proteoglycans of
the extracellular matrix also play key roles in blood vessel
formation, because heparan sulfate chains interact, accumulate
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locally, and promote interaction of pro-angiogenic growth
factors with their receptors.17−22 The lack of heparan sulfate
groups is known to impair angiogenesis and delay the healing of
wounds. In addition, binding to heparan sulfate proteoglycans
protects growth factors from proteolytic degradation.23
Peptide amphiphiles are composed of bioactive peptide
sequences and hydrophobic alkyl chains, and can self-assemble
into nanofibrous structures through electrostatic, hydrophobic
and van der Waals interactions.24,25 These molecules are
frequently used in directing the lineage commitment of cells
with the aid of tissue-specific bioactive signals integrated into
their sequences.25,26 The nanofibrous scaffolds that are formed
through self-assembly of bioactive peptide amphiphile mole-
cules mimic the structural and functional properties of the
native ECM environment, allowing great control over cellular
behavior.27 These peptide nanofiber networks are biocompat-
ible and biodegradable, which makes them highly promising
materials for use as functional scaffolds in neural,28−30 bone,31
cornea,32 enamel,33 and cartilage34 regeneration and angio-
genesis.35 Peptide amphiphile nanofibers with heparin-binding
groups were previously shown to enhance angiogenesis when
administered in conjunction with heparin molecules.36,37 We
previously demonstrated heparin-mimetic peptide amphiphile
(HM-PA) nanofibers, which are able to induce the formation of
tubular structures by endothelial cells through their presenta-
tion of sulfonate, carboxylate and hydroxyl groups.38 Angio-
genic activity was observed even in the absence of growth
factors and heparin, which suggests that endogenous growth
factors released from endothelial cells were sufficient for
angiogenesis with the aid of heparin mimetic peptide matrix.
The HM-PA was observed to induce angiogenesis both in vitro
and in vivo.38 The angiogenic activity of HM-PA stems from its
ability to bind heparin-binding growth factors such as vascular
endothelial growth factor (VEGF) and fibroblast growth factor-
2 (FGF-2), thereby increasing the local concentration of these
molecules.39
Here, we tested the ability of HM-PA gels to accelerate the
wound healing process in full-thickness rat skin injury model,
and investigated the structural regeneration, granulation, re-
eptihelization, angiogenesis and wound closure rates. Because
angiogenesis is a fundamental mechanism in wound healing
process, the HM-PA nanofibers were able to improve the
recovery of skin wounds by enhancing the formation of a blood
vessel network at the wound bed. The HM-PA gel treatment
provided a well-organized ECM-like environment for full-
thickness wounds and increased blood vessel density and
formation of skin appendages, while decreasing granulation
tissue formation after 14 days of application.
■ EXPERIMENTAL SECTION
Materials. 9-Fluorenylmethoxycarbonyl (Fmoc) and other pro-
tected amino acids, lauric acid, 4-(2′,4′-dimethoxyphenyl-Fmoc-
aminomethyl)-phenoxyacetamido-norleucyl MBHA resin (Rink
amide MBHA resin), 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluro-
nium hexafluorophosphate (HBTU), and diisopropylethylamine
(DIEA) were purchased from Merck. All chemicals were used as
provided.
Synthesis and Purification of Peptide Amphiphile Mole-
cules. A Fmoc solid-phase peptide synthesis protocol was employed
for the synthesis of peptide molecules. The positively charged HM-PA
(lauryl-VVAGEGD(K-pbs)S-Am) and K-PA (lauryl-VVAGK-Am)
were synthesized on Rink amide MBHA resin while negatively
charged E-PA lauryl-VVAGE) was constructed on Wang resin. The
activation of carboxylate groups was performed by 1.95 equiv. of
HBTU and 3 equiv. of DIEA for 1 molar equivalents of starting resin.
Amino acid coupling time was for 2 h. At each coupling step, samples
were treated with 20% piperidine/dimethylformamide solution
(DMF) for Fmoc group removal for 20 min. Unreacted amine groups
were permanently blocked with 10% acetic anhydride/DMF after each
coupling reaction. The resin was washed three times with DMF,
dichloromethane (DCM), and DMF, respectively. A lysine residue
with 4-methytrityl (Mtt) side-chain protection was used for selective
deprotection of amine groups. Mtt group removal was performed by
treating resins for 5 min with trifluoroacetic acid (TFA):triisopro-
pylsilane (TIS):H2O:DCM cocktail in the ratio of 5:2.5:2.5:90,
respectively. After Mtt removal, resins were washed with DCM and
DMF, respectively. Two molar equivalents of activated p-sulfobenzoic
acid by 1.95 molar equivalents of HBTU and 3 molar equivalents of
DIEA were dissolved in DMF. Coupling time was set to be 2.5 h. The
peptide amphiphile molecules were cleaved from the solid support in a
TFA:TIS:H2O cocktail (95% TFA, 2.5% water, 2.5% TIS) for 2 h at
room temperature and excess solution was removed by rotary
evaporator. Ice-cold diethyl ether was added to the remaining solution.
The solution was centrifuged to obtain a white precipitate, which was
dried under vacuum and reconstituted in water or culture medium
prior to use. All peptide molecules synthesized in this study are water-
soluble at physiological pH. Characterization of the peptide molecules
was performed by liquid chromatography and mass spectrometry (LC-
MS). LC-MS data were obtained using an Agilent 1200 LC system
equipped with an Agilent 6530 Q-TOF with an ESI source. A Zorbax
Extend-C18 2.1 × 50 mm column for basic conditions and a Zorbax
SB-C8 4.6 mm × 100 mm column for acidic conditions were used for
chromatographic separation. A gradient of water and acetonitrile,
containing 0.1% formic acid or 0.1% NH4OH, was used. Purification of
the PAs was performed by a reverse phase preparative high-
performance liquid chromatography (HPLC) (Agilent 1200 series)
system using a Zorbax Extend-C18 21.2 × 150 mm column. The
detection wavelength was selected as 220 nm. Concentration gradient
of mobile phase was hold as 2% acetonitrile (ACN) for 2 min and
ramp from 2% to 100% ACN for 20 min. Then, it was ramped from
100 to 2% ACN and was held as 2% ACN for 2 min, sequentially.
Scanning Electron Microscopy (SEM). A FEI Quanta 200 FEG
scanning electron microscope (SEM) was used to inspect the
nanofiber networks of HM-PA/K-PA and E-PA/K-PA mixtures
under high vacuum. One weight percent oppositely charged peptide
amphiphile solutions were mixed at a ratio of 1:1 (v/v) (final volume
being 30 μL) and incubated at room temperature for 15 min for
forming gels. Dehydration was performed by incubating the gels for 2
min in 20, 40, 60, 80, and 100% ethanol, sequentially. Following the
ethanol exchange, samples were dried in a critical point dryer
(Tousimis, Autosamdri-815B, Series C critical point dryer) in order to
preserve the original morphology. Samples were coated with 6 nm of
Au/Pd prior to imaging.
Oscillatory Rheology. Storage and loss moduli of HM-PA/K-PA
and E-PA/K-PA gels were measured at room temperature by
oscillatory rheology using a 25 mm parallel plate (Anton Paar Physica
RM301). One weight percent HM-PA/K-PA or E-PA/K-PA was
loaded on the center of the lower plate at a total volume of 300 μL and
incubated for 15 min prior to measurement. A gap distance of 0.3 mm
was used with an angular frequency range of 100−0.1 rad/s and a
shear strain of 0.5%.
In Vivo Wound Healing Model. In vivo experiments were carried
out with 3 month old (200−250 g) Wistar rats of both sexes (n = 16).
Animals were maintained on ad libitum access to water and nutrition
in a 12 h−12 h light−dark cycle. All procedures concerning animals
were approved by the Institutional Animal Care and Use Committee
of Diskapi Yildirim Beyazit Training and Research Hospital and all
experiments were performed accordingly.
Following the shaving and aseptic treatment of the dorsal area, three
full-thickness excisional wounds were created on the dorsal skin of rats
under general anesthesia. A 6 mm circular biopsy punch was used for
the wounding process. First, second, and third wounds were created 2,
4, and 6 cm distal to the ears, respectively. The gels were immediately
applied to prevent dryness and reapplied on day 1. Final
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concentrations of peptide amphiphile solutions were 1 wt % HM-PA
and 1 wt % K-PA or 1 wt % E-PA and 1 wt % K-PA, mixed at a ratio of
1:1 (v/v). The E-PA/K-PA combination was used as a nonbioactive
nanofiber control, and 0.25 M sucrose solution was used as negative
control. As wound location may alter the healing process through
effects such as movement-mediated stretching, peptide nanofiber and
control treatments were distributed evenly across distal, median and
proximal wounds. Following peptide nanofiber gel application, wounds
were covered with NU-DERM Alginate (Systagenix) as a wound
dressing. An adhesive, elastic, nonwoven bandage (OctaCare,
Octamed) was placed over the wound to prevent the spillage of
gels. Rats were allowed to eat and drink ad libitum after the operation
and routine controls for infection were performed throughout the
study.
Wound boundaries were observed and wound areas were measured
using ImageJ software (NIH, USA) on days 3, 7, 10, and 14 following
the operation. Rats were euthanized at seventh (n = 8) and 14th (n =
8) days following the operation and the wounds and their surrounding
areas were surgically excised. Wound area closure was calculated by
using the following formula
= t
wound area ratio (%)
(wound area on day /wound area on day 0)100
= −wound closure (%) 1 wound area ratio (%)
Histological Analyses. Skin tissues from the sacrificed rats were
collected and fixed in 10% buffered formalin. Tissues were dehydrated
with 70, 80, 95, and 100% ethanol series for 2 h each, and then they
were treated with xylene and embedded in paraffin blocks. Sectioning
at 5 μm was performed via Leica microtome. Hematoxylin & eosin
(H&E) and Masson’s trichrome staining were performed according to
standard protocols following deparaffinization and rehydration by
xylene and serially decreasing concentrations of ethanol (100, 95, and
70% ethanol and water, sequentially). For immunohistochemistry
experiments, the sections were labeled with anti-von Willebrand Factor
(1:400; Abcam) antibody and horseradish peroxidase-conjugated goat
Figure 1. Chemical structures of self-assembling peptide amphiphile molecules; HM-PA, E-PA, and K-PA.
Figure 2. Characterization of the peptide amphiphile scaffolds at pH 7.4. Scanning electron microscopy (SEM) images of (A) HM-PA/K-PA and
(B) E-PA/K-PA reveal ECM-like morphology of scaffolds. (C) Mechanical properties of the PA gels. Rheology results showed that HM-PA/K-PA
and E-PA/K-PA combinations formed gels and that their mechanical properties are similar. Scale bars are 5 μm.
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antimouse secondary antibody (1:500; Millipore). Antibody labeling
was followed by 3,3′-diaminobenzidine (DAB) staining and
hematoxylin counterstaining. Mounting was performed for all samples
using a xylene-based mounting medium. Digital images were acquired
using a Zeiss Axio Scope A1 microscope. Granulation tissue areas of
the samples were measured with ImageJ, blood vessel numbers were
quantified from sections stained with anti-von Willebrand factor
antibody. Re-epithelization was quantified by measuring the distance
between left and right wound edges; total re-epithelized tissue area was
taken as the sum of new epithelium produced at the left and right
edges of the wound. Images were acquired using 10× or 20×
objectives and analyzed with ImageJ.
Statistical Analysis. Statistical analyses were performed by using
GraphPad Prism 5. One-way ANOVA with Bonferroni multiple
comparisons test was employed to determine statistical differences
between groups. The level of significance was set at p < 0.05. Error
bars indicate standard error of mean.
■ RESULTS
The HM-PA nanofibers (bioactive peptide, lauryl-
VVAGEGDK(pbs)S-Am) mimic the activity of heparan sulfates
by presenting sulfonate, hydroxyl and carboxylate groups on
amino acid side chains (Figure 1). The HM-PA and E-PA
(negatively charged nonbioactive peptide, Lauryl-VVAGE)
molecules form gels through charge neutralization when
mixed with K-PA (positively charged nonbioactive peptide,
Lauryl-VVAGK-Am) molecule at physiological pH. All peptide
amphiphile molecules were characterized by liquid chromatog-
raphy−mass spectrometry (LC−MS) and purified by prepara-
tive HPLC (Figures S1−S3). SEM images of HM-PA/K-PA
and E-PA/K-PA networks exhibited porous and nanofibrous
structures that resemble the natural architecture of the ECM
(Figure 2a, b). Mechanical properties of the peptide amphiphile
gels were analyzed by oscillatory rheology measurements and
both HM-PA/K-PA and E-PA/K-PA scaffolds were found to
have higher storage moduli (G′) than loss moduli (G″),
suggesting that both materials are gels (Figure 2c).
The HM-PA/K-PA and E-PA/K-PA gels were applied
topically on full-thickness excision wounds immediately and
24 h after injury. Wounds were observed to be normal and no
evidence of infection was observed during the experimental
period. Treatment groups were distributed evenly across distal,
median and proximal wounds to eliminate the potential effect
of wound site on the healing process. Wound areas were
measured on day 3, 7, 10, and 14 (Figure S4) to evaluate the
recovery associated with each treatment and wound location.
The HM-PA/K-PA treated wounds showed sustained healing
process even after day 10 (p < 0.01) and reached to 93%
wound closure on day 14, while the recovery of sucrose and E-
PA/K-PA treated wounds stopped on day 14 and were 79 and
86%, respectively (Figure 3). Wound healing rates of different
wound locations were also compared to observe the effect of
wound placement on healing, but no significant differences
were observed among the experimental groups, except between
E-PA/K-PA and HM-PA/K-PA on day 3 in the proximal
wound area (Figure S5).
In normal wound healing, the proliferation phase peaks at 7
days following the injury and is characterized by granulation
tissue formation, re-epithelization and angiogenesis. H&E and
Masson’s trichrome stainings of wound areas revealed that the
HM-PA/K-PA gel-treated group exhibits a collagen-rich
granulation tissue that is less edematous and better organized
compared to controls on day 7 (Figure 4). Although
Figure 3. Wound area ratios of (a) sucrose-, (b) E-PA/K-PA-, and (c) HM-PA/K-PA-treated wounds on days 3, 7, 10, and 14 to that of day 0. * p <
0.05.
Figure 4. Hematoxylin & eosin (upper panel) and Masson’s trichrome staining (lower panel) of sucrose, E-PA/K-PA, and HM-PA/K-PA treatment
on day 7. Scale bars are 200 μm.
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granulation areas of all samples were comparable in size (Figure
6b), the granulation tissue of E-PA/K-PA and control groups
had less uniform connective tissue and poorly organized
collagen fibers on day 7 (Figure 4). Although a homogeneous,
thick, and well-organized granulation tissue could be observed
in control groups by day 14 (Figure 5), the HM-PA/K-PA-
treated wounds exhibited decreased granulation tissue area and
developed a relatively thick basket-weave network of collagen
fibers.
Granulation tissue also stimulates uninjured keratinocytes to
migrate through the wound area to form a new epithelial layer;
as such, re-epithelialization was also quantified by measuring
the epithelium advancing from wound edges. HM-PA/K-PA
treated wounds displayed more advanced re-epithelialization on
day 7 compared to E-PA/K-PA and sucrose groups (Figure 6a).
Figure 5. Hematoxylin & eosin (upper panel) and Masson’s Trichrome staining (lower panel) of sucrose, E-PA/K-PA, and HM-PA/K-PA
application on day 14. Black arrows indicate rete ridge formation. Scale bars are 200 μm.
Figure 6. Quantitative analysis of (a) re-epithelization, (b) granulation tissue, and (c) skin appendage number of wound tissues.
Figure 7. (a−c) Staining of blood vessels by anti-von Willebrand factor and (d, e) quantification of blood vessels on days 7 and 14. Representative
sections obtained from (a) sucrose, (b) E-PA/K-PA, and (c) HM-PA/K-PA on day 7, 200× magnification. Scale bars are 100 μm.
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Wounds were fully re-epithelialized on day 14 for all
experimental groups. Skin appendages were observed to form
in all of the HM-PA/K-PA gel treated wounds, whereas control
animals lacked skin appendage formation.
Because HM-PA was previously shown to enhance angio-
genesis both in vitro and in vivo, and angiogenesis is vital for
scar-free wound healing process, we analyzed angiogenesis in
tissue sections in order to analyze whether the enhancement in
gross morphology of the HM-PA treated groups was due to
increased angiogenesis. Anti-von Willebrand factor staining and
vascularization assessments were also performed to study the
angiogenic responses (Figure 7). Importantly, these results
showed that HM-PA/K-PA treatment promoted neovasculari-
zation more than both nonbioactive nanofiber treatment and
sucrose treatment on day 7 (Figure 7). This increase in blood
vessel number was normalized to control treatment groups on
day 14, which suggests that the enhanced angiogenesis was not
pathological.
■ DISCUSSION
Effective wound healing is a major concern for modern
medicine, and even fully closed wounds do not fully regain their
former functionality due to scar formation.35 Although skin
substitutes are commonly used to reduce scarring, their utility is
limited by issues such as reduced vascularization, mechanical
instability, handling issues, lack of biocompatibility, and costs.
Artificial scaffolds, which restore the structural and functional
properties of skin by modulating the wound repair process, are
attractive alternatives to traditional skin substitutes.40 In
particular, hydrogel-based scaffolds are promising materials
for this purpose.41−43
In this study, we utilized a bioactive peptide nanofiber system
to promote the wound healing process while minimizing scar
formation. These nanofibers are designed to mimic heparin and
were previously shown to enhance angiogenesis in vitro and in
vivo by increasing the local concentration of angiogenic growth
factors.38,39 The peptide amphiphile molecules are composed of
a hydrophobic alkyl tail conjugated to hydrophilic amino acid
units and can form self-assembled structures through non-
covalent interactions (Figure 1).44,45 In our previous studies, it
has been shown that nanofibers of ca. 20−30 nm diameters
were formed upon mixing positively charged K-PA molecules
and negatively charged HM-PA or E-PA molecules,38,46 which
self-assemble through electrostatic interactions, β-sheet for-
mation, and hydrophobic collapse. The β-sheet-driven nano-
fiber elongation was provided by the VVAG motif, as the valine
amino acid has a high tendency to form β-sheets.45 The wound
healing process requires the isolation of the wound from the
outside environment in addition to high porosity for gas
exchange, and peptide nanofibers are able to satisfy both criteria
by forming biodegradable porous gel networks. In addition, the
bioactive epitopes presented on nanofiber surfaces further
allowed the modulation of cell behavior at the wound site
(Figure 2).
Wounded area treated with the HM-PA gels continued to
decrease after day 10, whereas wound closure stopped in
control groups on day 10 (Figure S4). The main challenge of
wound healing is enhancing regeneration while minimizing scar
formation, and thus the continuation of wound repair after day
10 may suggest that the HM-PA gel was able to facilitate the
scar-free healing of skin wounds.
Skin scars are generally characterized by the deposition of
fibrotic tissue, reduced epidermal appendages, alterations in
collagen organization and a smooth appearance.10,47 Con-
sequently, we investigated the histological appearance of
regenerating skin tissue on days 7 and 14 (which mark the
points at which proliferation peaks and remodeling starts,
respectively) to observe scar formation in the presence and
absence of bioactive PA nanofibers. Histological analyses
showed that HM-PA/K-PA-treated wounds exhibited a
decrease in granulation tissue on day 14 and closely resembled
the original tissue in structure (Figures 5 and 6b). Re-
epithelization also increased on day 7 following HM-PA/K-PA
treatment (Figure 6a) and was completed by day 14.
Interestingly, there was a trend for enhanced skin appendage
regeneration in the HM-PA/K-PA gel treated wounds
compared control groups. Skin appendages can be regenerated
in partial thickness wounds, but not in full thickness wounds.48
Although Wnt signaling triggers de novo hair follicle
production from epidermal progenitor cells,49 skin appendages
are nonetheless reduced in wounded tissues.10,11 This down-
ward tendency may result in lower densities of rete ridge in
wounded tissues. In our study, HM-PA/K-PA treatment was
observed to increase rete ridges (Figure 5, black arrows).50
Reduced or diminished angiogenesis is one of the main issues
in therapeutic approaches for wound healing, especially for
maintaining the long-term survival of skin grafts, as the rapid
vascularization of the wound area is difficult to achieve. It has
been shown that annexin A5 expression, which is a late
apoptotic marker, leads the cell death in reduced angiogenesis
which is found in impaired wounds.51 Several growth factors
are known to modulate angiogenesis during wound healing.
Damaged endothelial cells secrete fibroblast growth factor 2
(FGF-2)6,52 and inhibiting FGF-2 activity in wounded areas
prevents angiogenesis. In addition, it is known that FGF-2 is
involved in scarless healing47 and affects the vascularization of
artificial derma.52,53 The other key regulator of angiogenesis is
vascular endothelial growth factor (VEGF), which has been
reported to promote wound healing in diabetic animal
models.52,54 In addition to FGF-2 and VEGF, hepatocyte
growth factor (HGF) is important for neovascularization during
wound healing, and assists in the repair of the epithelial layer by
regulating cell growth and motility.55−57 The HM-PA nano-
fibers have the ability to induce capillary-like structures in vitro
and in vivo through its strong binding affinity to HGF, VEGF,
and FGF-2.38,39 To investigate whether the improvements in
skin regeneration is promoted by the increased formation of
new blood vessels within the granulation area, we investigated
angiogenesis in injured tissues on day 7 (Figure 6). There was a
significant increase in the number of blood vessels in HM-PA/
K-PA-treated wounds on day 7 compared to nonbioactive
nanofiber and no treatment control, which suggests that the
increased healing capacity of the HM-PA/K-PA-treated wounds
might be due to increased angiogenesis. Furthermore, the
regression of angiogenesis, which is required for the latter
phases of wound healing, was observed in both HM-PA and
control groups by day 14. Fetal wounds heal without scarring
and some studies have suggested that decreased angiogenesis
can cause scarless healing,58−60 and thus, timely regression of
the capillary network is advantageous for the peptide nanofiber
gel enhanced wound healing process. The PA combinations
used in this study were mixed and incubated prior to
characterization or application in order to provide homoge-
neous and mature gel formation. However, because PA gels are
injectable, using a double syringe method may provide ease of
implementation for future applications.
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■ CONCLUSION
In this study, we showed that heparin-mimetic peptide
amphiphile nanofiber gels are useful for inproving the
functional wound healing process using a rat full thickness
wound model. The HM-PA nanofiber gels exhibit features
similar to native ECM. Although wound closure rates of the
wounds treated with HM-PA/K-PA, E-PA/K-PA, and sucrose
combinations were similar, the HM-PA/K-PA group exhibited
faster regeneration and better organization of the wound area as
indicated by an increasing trend of skin appendages and rete
ridge formations. In addition, significant differences in re-
epithelization and granulation tissue formation rates were
observed between bioactive and control groups on day 14 and
day 7, respectively. Furthermore, increased density of newly
formed blood vessels in the bioactive PA-treated group on day
7, which was followed by regression by day 14, suggests that a
rapid course of regeneration is followed in HM-PA-treated
groups. Because prompt wound healing is crucial for protecting
the wounded area, heparin-mimetic peptide nanofibers may be
utilized as a novel therapeutic approach for regenerative wound
healing with minimal scar formation.
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